Prostate Cancer and Prostatic Diseases : Impact Factor & More
eISSN: 1476-5608pISSN: 1365-7852
Share this on:
Key Metrics
CiteScore 
7.8
H-Index
74
Impact Factor
< 5
SJR
Q1Urology
SNIP
1.72
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Prostate Cancer and Prostatic Diseases
Prostate Cancer and Prostatic Diseases Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | SPRINGERNATURE |
| Language | English |
| Frequency | Quarterly |
| General Details | |
| Language | English |
| Frequency | Quarterly |
| Publication Start Year | 1997 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Prostate Cancer and Prostatic Diseases ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Prostate Cancer and Prostatic Diseases
En-bloc vs lobe-by-lobe laser prostatectomy: where do we stand?
- 24 Jun 2026
- Prostate cancer and prostatic diseases
Methodological and clinical considerations of MRI-based prostate cancer risk calculators.
- 22 Jun 2026
- Prostate cancer and prostatic diseases
Response to de Riese et al. regarding "methodological and clinical considerations of MRI-based prostate cancer risk calculators".
- 22 Jun 2026
- Prostate cancer and prostatic diseases
Efficacy and safety of darolutamide plus androgen-deprivation therapy in Black patients with metastatic hormone-sensitive prostate cancer from the phase 3 ARANOTE trial.
- 20 Jun 2026
- Prostate cancer and prostatic diseases
Association between concomitant ACEI/ARBs use and survival of patients with prostate cancer receiving abiraterone acetate: A post-hoc analysis of two randomized trials.
- 12 Jun 2026
- Prostate cancer and prostatic diseases
Zenflow spring system for benign prostatic hyperplasia - 24 month outcomes of the ZEST pilot studies.
- 9 Jun 2026
- Prostate cancer and prostatic diseases
En-bloc vs lobe-by-lobe laser prostatectomy: where do we stand?
- 24 Jun 2026
- Prostate cancer and prostatic diseases
Methodological and clinical considerations of MRI-based prostate cancer risk calculators.
- 22 Jun 2026
- Prostate cancer and prostatic diseases
Response to de Riese et al. regarding "methodological and clinical considerations of MRI-based prostate cancer risk calculators".
- 22 Jun 2026
- Prostate cancer and prostatic diseases
Efficacy and safety of darolutamide plus androgen-deprivation therapy in Black patients with metastatic hormone-sensitive prostate cancer from the phase 3 ARANOTE trial.
- 20 Jun 2026
- Prostate cancer and prostatic diseases
Association between concomitant ACEI/ARBs use and survival of patients with prostate cancer receiving abiraterone acetate: A post-hoc analysis of two randomized trials.
- 12 Jun 2026
- Prostate cancer and prostatic diseases
Zenflow spring system for benign prostatic hyperplasia - 24 month outcomes of the ZEST pilot studies.
- 9 Jun 2026
- Prostate cancer and prostatic diseases
FAQs on Prostate Cancer and Prostatic Diseases
How long has Prostate Cancer and Prostatic Diseases been actively publishing? 
What is the publishing frequency of Prostate Cancer and Prostatic Diseases?
How many articles did Prostate Cancer and Prostatic Diseases publish last year?
What is the eISSN & pISSN for Prostate Cancer and Prostatic Diseases?
What is Citescore for Prostate Cancer and Prostatic Diseases?
What is the H Index for Prostate Cancer and Prostatic Diseases ?
What is SNIP score for Prostate Cancer and Prostatic Diseases?
What is the SJR for Prostate Cancer and Prostatic Diseases?
Who is the publisher of Prostate Cancer and Prostatic Diseases?
